Ultragenyx Pharmaceutical Inc.
NASDAQUltragenyx Pharmaceutical heads into the post-earnings week with short sellers adding positions and analysts pulling in opposite directions — a split that reflects the market's unresolved read on whether the Q1 revenue miss is seasonal noise or something more worrying. Short interest is rising meaningfully, and has been for a month. SI as a percentage of the free float climbed…
Snapshot as of 7 May 2026
Ultragenyx Pharmaceutical heads into the post-earnings week with short sellers adding positions and analysts pulling in opposite directions — a split that reflects the market's unresolved read on whether the Q1 revenue…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RARE — free to start on ORTEX.
Sign up for free →Open RARE on ORTEX